LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: Abundance and Associated Variations of Cytochrome P450 Drug-Metabolizing Enzymes in the Liver of East Asian Adults: A Meta-Analysis.

    An, Xiao-Xiao / Yu, Yichao / Li, Guo-Fu / Yu, Guo

    European journal of drug metabolism and pharmacokinetics

    2020  Volume 46, Issue 2, Page(s) 225–233

    Abstract: Background: Cytochrome P450 (CYP) enzymes are one of the main sources of variability in drug metabolic clearance. Information on their abundance levels is therefore crucial to optimize scaling factors for in vitro-in vivo extrapolation (IVIVE) to ... ...

    Abstract Background: Cytochrome P450 (CYP) enzymes are one of the main sources of variability in drug metabolic clearance. Information on their abundance levels is therefore crucial to optimize scaling factors for in vitro-in vivo extrapolation (IVIVE) to predict metabolic clearance.
    Objective: This study aims to quantify the abundance data of hepatic drug-metabolizing CYP enzymes in East Asian subjects reported from various sources in the literature using meta-analysis.
    Method: We conducted a meta-analysis on the abundance of drug-metabolizing CYP enzymes in the liver of East Asian adults. Eligible reports were identified based on predefined criteria-(1) individual liver microsomal samples, and (2) absolute protein abundance data from normal tissues of East Asian adult subjects. Subgroup and sensitivity analyses were also performed.
    Results: Among the 11 CYP isoforms analyzed in East Asian subjects, CYP3A5 and CYP3A4 had the highest protein levels. In particular, the number of studies and the liver sample used to quantify the abundance of CYP3A4 were the largest. Of the isoforms involved, CYP2J2 and CYP2B6 had the lowest abundance level, i.e., <5 pmol/ mg of microsomal protein. For enzymes with abundance values available in both Chinese and Japanese subjects (CYP1A2, CYP2C9, CYP3A4, and CYP3A5), the abundance level of each CYP isoform appeared to be higher in Chinese than in Japanese subjects. The most distinct difference was observed in CYP3A5 abundance.
    Conclusion: The current meta-analysis shows that the abundance levels of CYP enzymes appear to vary greatly among different East Asian individuals who have similar ethnic backgrounds and food habits. The pooled data of CYP abundance can be used as preliminary reference values along with the associated variations for the projections of pharmacokinetics through physiologically based pharmacokinetic (PBPK) approaches.
    MeSH term(s) Adult ; Asian Continental Ancestry Group ; Cytochrome P-450 Enzyme System/metabolism ; Humans ; Liver/enzymology ; Microsomes, Liver/enzymology ; Pharmaceutical Preparations/metabolism
    Chemical Substances Pharmaceutical Preparations ; Cytochrome P-450 Enzyme System (9035-51-2)
    Language English
    Publishing date 2020-04-21
    Publishing country France
    Document type Journal Article ; Meta-Analysis ; Systematic Review
    ZDB-ID 196729-0
    ISSN 2107-0180 ; 0398-7639 ; 0378-7966
    ISSN (online) 2107-0180
    ISSN 0398-7639 ; 0378-7966
    DOI 10.1007/s13318-020-00667-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Pooled Analysis of Gastric Emptying in Patients With Obesity: Implications for Oral Absorption Projection.

    Lu, Chen-Xi / An, Xiao-Xiao / Yu, Yichao / Jiao, Li-Rong / Canarutto, Daniele / Li, Guo-Fu / Yu, Guo

    Clinical therapeutics

    2021  Volume 43, Issue 10, Page(s) 1768–1788

    Abstract: Purpose: Gastric emptying time is one of limiting factors that determines the pharmacokinetic properties of drugs administered by mouth. Despite the high prevalence of obesity worldwide, modifications in gastric emptying time have not been ... ...

    Abstract Purpose: Gastric emptying time is one of limiting factors that determines the pharmacokinetic properties of drugs administered by mouth. Despite the high prevalence of obesity worldwide, modifications in gastric emptying time have not been systematically addressed in this set of patients. The current analysis aims to quantitatively address obesity-related changes in gastric emptying time of solids, semisolids, and liquids compared with lean individuals, highlighting the relevant pharmacokinetic implications of oral drug absorption in patients with obesity.
    Methods: We searched the Cochrane Library, PubMed, Web of Science, and Embase for all relevant articles published until November 1, 2020. Differences in gastrointestinal variables in relation to gastric emptying between obese and lean individuals were quantified by weighted mean difference (WMD) and ratio of means (RoM). Robustness of the analyses was evaluated by subgroup analysis and publication bias test.
    Findings: A total of 17 studies with 906 participants were included. The gastric half-emptying time of solids (WMD, -10.4 minutes; P = 0.001; RoM, 0.90; P = 0.01) and liquids (WMD, -6.14 minutes; P < 0.001; RoM, 0.83, P = 0.03) was significantly shorter in individuals with obesity compared with lean individuals. These findings were confirmed by the subgroup analyses and publication bias tests.
    Implications: Our pooled analysis systemically quantifies the differences in gastric half-emptying time between individuals with obesity and lean individuals, facilitating better understanding and prediction of drug absorption in individuals with obesity through physiologically based pharmacokinetic approaches. Obesity is associated with a faster transit of both solids and liquids through the stomach.
    MeSH term(s) Gastric Emptying ; Humans ; Obesity ; Pharmaceutical Preparations
    Chemical Substances Pharmaceutical Preparations
    Language English
    Publishing date 2021-09-03
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 603113-4
    ISSN 1879-114X ; 0149-2918
    ISSN (online) 1879-114X
    ISSN 0149-2918
    DOI 10.1016/j.clinthera.2021.08.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Do proton pump inhibitors influence SARS-CoV-2 related outcomes? A meta-analysis.

    Li, Guo-Fu / An, Xiao-Xiao / Yu, Yichao / Jiao, Li-Rong / Canarutto, Daniele / Yu, Guo / Wang, Guangji / Wu, Dan-Na / Xiao, Yin

    Gut

    2020  Volume 70, Issue 9, Page(s) 1806–1808

    MeSH term(s) COVID-19 ; Gastroesophageal Reflux ; Humans ; Proton Pump Inhibitors/adverse effects ; SARS-CoV-2
    Chemical Substances Proton Pump Inhibitors
    Keywords covid19
    Language English
    Publishing date 2020-11-10
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 80128-8
    ISSN 1468-3288 ; 0017-5749
    ISSN (online) 1468-3288
    ISSN 0017-5749
    DOI 10.1136/gutjnl-2020-323366
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Do proton pump inhibitors influence SARS-CoV-2 related outcomes? A meta-analysis

    Li, Guo-Fu / An, Xiao-Xiao / Yu, Yichao / Jiao, Li-Rong / Canarutto, Daniele / Yu, Guo / Wang, Guangji / Wu, Dan-Na / Xiao, Yin

    Gut

    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #919103
    Database COVID19

    Kategorien

To top